2019
DOI: 10.1007/s10140-019-01736-6
|View full text |Cite
|
Sign up to set email alerts
|

Vaping-associated acute respiratory distress syndrome

Abstract: Vaping-associated lung injury via the use of electronic nicotine delivery systems (ENDS) is currently being evaluated as a potential source of pulmonary injury with uncertain etiology as the use of tetrahydrocannabinol (THC) is increasing throughout the USA. ENDS are marketed to be unlike traditional cigarette smoking in that they are purported to contain only propylene glycol, vegetable glycerine, nicotine, and flavorants compared with the > 60 carcinogenic ingredients in cigarettes. The New England Journal o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(35 citation statements)
references
References 16 publications
1
33
0
1
Order By: Relevance
“…Tables 2 and 3. Most common diagnosis was EVALI (n = 15) [26][27][28][29][30][31][32][33][34][35][36] or EVALI with an additional finding (n = 1) [37]. Second most common diagnosis included either organizing pneumonia/ Bronchiolitis obliterans with organizing pneumonia (BOOP)/ respiratory bronchiolitis (n = 12) [38][39][40][41][42][43][44][45][46] or lipoid pneumonia (n = 9) [11,[47][48][49][50][51].…”
Section: Classification Of Casesmentioning
confidence: 99%
“…Tables 2 and 3. Most common diagnosis was EVALI (n = 15) [26][27][28][29][30][31][32][33][34][35][36] or EVALI with an additional finding (n = 1) [37]. Second most common diagnosis included either organizing pneumonia/ Bronchiolitis obliterans with organizing pneumonia (BOOP)/ respiratory bronchiolitis (n = 12) [38][39][40][41][42][43][44][45][46] or lipoid pneumonia (n = 9) [11,[47][48][49][50][51].…”
Section: Classification Of Casesmentioning
confidence: 99%
“…Pathological outcomes of vaping vary dramatically in humans as well as laboratory models, but occurrence of severe VAPI in the clinical setting is a serious and growing concern in society. (10)(11)(12)(13)(14)(15)(16)(17) The VAPI model developed in this report provides an experimental platform for this understudied syndrome, exhibiting a collective set of distinguishing characteristics without precedent in the literature. Foremost, phenotypic manifestations are reminiscent of clinical case reports of individuals hospitalized for severe VAPI including tissue damage, inflammatory responses, and cardiopulmonary failure.…”
Section: Discussionmentioning
confidence: 99%
“…1-8) demonstrates severe damage to lung tissue. The clinical syndrome of severe VAPI has been associated with cardiac dysfunction (15,16,50) prompting assessment of myocardial structure and function in vaped mice following the 9…”
Section: Upper Airway Upregulates Transcriptome Markers Representing Mitochondrial Alterationsmentioning
confidence: 99%
“…AnĂĄlise anatomopatolĂłgica foi realizada em 164 desses indivĂ­duos, (material via broncoscopia) e achados mais frequentes: dano alveolar difuso, hemorragia 8 alveolar; pneumonia lipoide, proteinose alveolar e BOOP em alguns casos. 2,4,5,6,18,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49…”
Section: Fonte: Dados Coletados Pelos Autoresunclassified